ArticleOpen forum infectious diseases2022

Characterization of Early-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients Who Received Tixagevimab-Cilgavimab Prophylaxis.

Eloy E Ordaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.